37-7-406. Standards for prospective drug utilization review and patient counseling. (1) The board may by rule set standards for the provision of prospective drug utilization review information from a pharmacist to a patient before a prescription is dispensed to the patient or his representative. The review may include, when applicable, an appropriate level of screening for potential drug therapy problems due to therapeutic duplication, drug disease contraindications, drug interactions, incorrect drug dosage or duration of drug treatment, drug-allergy interactions, and clinical abuse or misuse. The sources for the standards must be nationally recognized compendia as the board may designate.
     (2) Under the standards provided for in this section, the pharmacist should offer to discuss those matters that, in his professional judgment, he considers significant to the patient's safe and proper use of the prescribed drug. The counseling should encompass the topics set forth in 42 U.S.C. 1396r-8 of the Social Security Act.
     (3) Communications between a pharmacist and a patient pursuant to the standards provided for in this section constitute health care information for the purposes of Title 50, chapter 16, part 5.
     (4) Standards established by the board under this section apply to all patients seen by a pharmacist or to categories of patients as the board may designate. However, standards provided for in this section may not apply to inpatients of a health care facility in which a nurse or other licensed health care professional is authorized to administer the prescribed drug.

     History: En. Sec. 1, Ch. 664, L. 1991.